French Biotech Stocks

Sanofi

Market Cap: €122.1b

A healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally.

Eurofins Scientific

Market Cap: €9.3b

Provides various analytical testing and laboratory services worldwide.

Ipsen

Market Cap: €8.9b

Operates as a biopharmaceutical company worldwide.

Virbac

Market Cap: €2.6b

Manufactures and sells a range of products and services for companion animals and farm animals in France, Europe, Latin America, North America, Asia, Pacific, and Africa and the Middle East.

Vetoquinol

Market Cap: €912.3m

A veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region.

Valneva

Market Cap: €515.1m

A specialty vaccine company, develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet needs.

MedinCell

Market Cap: €460.2m

A pharmaceutical company, develops long acting injectables in various therapeutic areas in France.

Boiron

Market Cap: €436.7m

Manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally.

Euroapi

Market Cap: €247.7m

Develops, manufactures, markets, and distributes active pharmaceutical ingredients and intermediates used in the formulation of medicines for human and veterinary use.

Eurobio Scientific Société anonyme

Market Cap: €246.6m

Engages in the design, development, and commercialization of in vitro diagnostics products in the areas of transplantation, immunology, infectious diseases, life-science, and cancer.

Genfit

Market Cap: €163.1m

A late-stage biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases.

Innate Pharma

Market Cap: €152.5m

A biotechnology company, develops immunotherapies for cancer patients in France and internationally.

OSE Immunotherapeutics

Market Cap: €120.5m

A clinical-stage biotechnology company, develops immunotherapies in the areas of immune-oncology and immune-inflammation in France and internationally.

Eurofins-Cerep

Market Cap: €103.9m

Provides various drug discovery services to pharmaceutical, biopharmaceutical, and biotechnology companies France and internationally.

Oncodesign Société Anonyme

Market Cap: €99.4m

Oncodesign Société Anonyme, a biopharmaceutical company, conducts research and development work on new therapeutic and diagnostic tools with pharmaceutical firms, biotech companies, public research institutions, and investment groups.

Cellectis

Market Cap: €85.1m

A clinical stage biotechnological company, develops products based on gene-editing with a portfolio of allogeneic chimeric antigen receptor T-cells product candidates.

Novacyt

Market Cap: €34.8m

Provides in vitro and molecular diagnostic tests for a range of infectious diseases in the United Kingdom, rest of Europe, France, the United States, the Asia Pacific, the Middle East, and Africa.

Valbiotis

Market Cap: €16.6m

Engages in the research and development of dietary supplements to prevent metabolic and cardiovascular diseases in France.

Aelis Farma

Market Cap: €16.3m

A clinical-stage biotechnology company, focuses on discovering and developing drug candidates for the treatment of central nervous system disorders.

Pherecydes Pharma Société anonyme

Market Cap: €14.4m

Pherecydes Pharma Société anonyme develops antibacterial treatments based on the use of bacteriophage viruses or phages.

IntegraGen

Market Cap: €3.5m

Provides researchers with sequencing solutions, data management tools, and biostatistical, and bioinformatics support services in France.

TheraVet

Market Cap: €292.7k

A veterinary biotechnology company, provides osteoarticular treatments for animals in Belgium, France, Switzerland, the United Kingdom, and the United States.